Pericarditis Due to Interferon-alpha Therapy During Treatment for Chronic Hepatitis C

Overview

Journal Acta Gastroenterol Belg

Specialty Gastroenterology

Date 2004 Dec 14

PMID 15587340

Citations 8

Authors

B Gressens

P Gohy

Affiliations

Soon will be listed here.

Abstract

Pericarditis due to interferon alpha therapy during treatment for chronic hepatitis C. We report a patient with pericarditis during therapy with interferon alpha 2b for chronic hepatitis C viral infection. We review interferon alpha therapy and hepatitis C virus side-effects on the cardiovascular system.

Citing Articles

Development of latent Interferon alpha 2b as a safe therapeutic for treatment of Hepatitis C virus infection.

Gull I, Aslam M, Tipu I, Mushtaq R, Ali T, Athar M Sci Rep. 2019; 9(1):10867.

PMID: 31350425 PMC: 6659634. DOI: 10.1038/s41598-019-47074-y.

Nishio K, Arase T, Tada H, Tachibana H World J Cardiol. 2017; 9(6):553-557.

PMID: 28706591 PMC: 5491473. DOI: 10.4330/wjc.v9.i6.553.

Interferon-α and pericardial injury: a case report and literature review.

Hakim F, Singh S, Pandit A, Alegria J, Camoriano J, Stanton M Heart Asia. 2016; 6(1):48-53.

PMID: 27326167 PMC: 4832724. DOI: 10.1136/heartasia-2013-010488.

Intrapericardial Delivery of Cardiosphere-Derived Cells: An Immunological Study in a Clinically Relevant Large Animal Model.

Blazquez R, Sanchez-Margallo F, Crisostomo V, Baez C, Maestre J, Alvarez V PLoS One. 2016; 11(2):e0149001.

PMID: 26866919 PMC: 4750976. DOI: 10.1371/journal.pone.0149001.

Side effects of cytokines approved for therapy.

Baldo B Drug Saf. 2014; 37(11):921-43.

PMID: 25270293 PMC: 7101846. DOI: 10.1007/s40264-014-0226-z.